ARROWHEAD PHARMACEUTICALS, INC. ($ARWR)
Filing Information
| Accession Number | 0001830755-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
40,164
Total Value
$2,534,661.46
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Sale | 4,625 | $61.24 | $283,235.00 | 207,497 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Sale | 6,090 | $62.28 | $379,285.20 | 201,407 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Sale | 14,792 | $63.01 | $932,043.92 | 186,615 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Sale | 12,711 | $63.95 | $812,868.45 | 173,904 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Sale | 1,200 | $64.49 | $77,388.00 | 172,704 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Sale | 437 | $65.97 | $28,828.89 | 172,267 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Sale | 309 | $68.00 | $21,012.00 | 171,958 | Direct | โ | View Details |